Cortical thickness correlated with peripheral inflammatory cytokines in amyotrophic lateral sclerosis

被引:0
作者
Yang, Jing [1 ,2 ,3 ]
Li, Wenyi [1 ,2 ,3 ]
Tian, Mei [1 ,2 ,3 ]
Zhang, Lei [4 ]
Du, Fengping [1 ,2 ,3 ]
Li, Xin [1 ,2 ,3 ]
Liu, Qi [1 ,2 ,3 ]
Li, Rui [1 ,2 ,3 ]
Li, Zhenzhong [1 ,2 ,3 ]
Dong, Hui [1 ,2 ,3 ]
Liu, Yaling [1 ,2 ,3 ]
机构
[1] Hebei Med Univ, Dept Neurol, Hosp 2, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Key Lab Neurol, Minist Educ, Shijiazhuang, Hebei, Peoples R China
[3] Neurol Lab Hebei Prov, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Med Univ, Hosp 2, Dept Emergency, Shijiazhuang, Hebei, Peoples R China
关键词
amyotrophic lateral sclerosis; cortical thickness; disease progression; inflammatory cytokines; MRI; PROGNOSTIC BIOMARKER; RATING-SCALE; ALS; MRI; NEUROINFLAMMATION; REACTIVITY; CORTEX; SYSTEM; SERUM;
D O I
10.3389/fnins.2024.1514554
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction Amyotrophic lateral sclerosis (ALS) is a rare, devastating neurodegenerative disease that affects upper and lower motor neurons, resulting in muscle atrophy, spasticity, hyperreflexia, and paralysis. Inflammation plays an important role in the development of ALS, and associated with rapid disease progression. Current observational studies indicate the thinning of cortical thickness in patients with ALS is associated with rapid disease progression and cognitive changes. However, the effects of inflammatory cytokines on cortical thickness in patients with ALS are unclear. Here, we investigated the relationship between inflammatory cytokines and cortical thickness in patients with ALS.Methods We evaluated 51 patients with ALS for inflammatory cytokines including interleukin (IL)-4, interferon (IFN)-alpha, IL-1 beta, IL-2, IL-5, IL-12, tumor necrosis factor (TNF)-alpha, IL-6, IL-10, IL-8, IL-17, and IFN-gamma and analyzed the correlation between these indicators and the ALS functional rating scale-revised (ALSFRS-R) score or disease progression rate (Delta FS score). Twenty-six patients with ALS and 26 controls were studied using whole-cortex analysis, and post-hoc analyses were performed to examine the correlation between brain cortical thickness and ALSFRS-R or Delta FS scores.Results IL-4, IFN-alpha, IL-1 beta, and IL-2 levels were significantly correlated with ALSFRS-R scores, and the IL-2 level was significantly correlated with Delta FS scores. After controlling for age and sex, the ALS group had thinner cortexes in multiple clusters across the brain than the control group. Further analyses revealed that cortical thickness in the right superior temporal and lingual gyrus regions was inversely correlated with Delta FS scores. There was a significant positive correlation between the clusters in the right lingual cortex and IL-2 level.Conclusion These results suggest cortical thickness was reduced in patients with ALS in motor and non-motor cortical areas. Inflammatory factors (especially IL-2) were correlated with cortical thickness, and both were related to the disease progression rate, suggesting IL-2 plays an important role in ALS.
引用
收藏
页数:11
相关论文
共 52 条
[1]   Immune reactivity in a mouse model of familial ALS correlates with disease progression [J].
Alexianu, ME ;
Kozovska, M ;
Appel, SH .
NEUROLOGY, 2001, 57 (07) :1282-1289
[2]   A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum [J].
Ambikairajah, Ananthan ;
Devenney, Emma ;
Flanagan, Emma ;
Yew, Belinda ;
Mioshi, Eneida ;
Kiernan, Matthew C. ;
Hodges, John R. ;
Hornberger, Michael .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (3-4) :226-234
[3]   Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies [J].
Beers, David R. ;
Appel, Stanley H. .
LANCET NEUROLOGY, 2019, 18 (02) :211-220
[4]   ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity [J].
Beers, David R. ;
Zhao, Weihua ;
Wang, Jinghong ;
Zhang, Xiujun ;
Wen, Shixiang ;
Neal, Dan ;
Thonhoff, Jason R. ;
Alsuliman, Abdullah S. ;
Shpall, Elizabeth J. ;
Rezvani, Katy ;
Appel, Stanley H. .
JCI INSIGHT, 2017, 2 (05)
[5]   A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BENSIMON, G ;
LACOMBLEZ, L ;
MEININGER, V ;
BOUCHE, P ;
DELWAIDE, C ;
COURATIER, P ;
BLIN, O ;
VIADER, F ;
PEYROSTPAUL, H ;
DAVID, J ;
MALOTEAUX, JM ;
HUGON, J ;
LATERRE, EC ;
RASCOL, A ;
CLANET, M ;
VALLAT, JM ;
DUMAS, A ;
SERRATRICE, G ;
LECHEVALLIER, B ;
PEUCH, AJ ;
NGUYEN, T ;
SHU, C ;
BASTIEN, P ;
PAPILLON, C ;
DURRLEMAN, S ;
LOUVEL, E ;
GUILLET, P ;
LEDOUX, L ;
ORVOENFRIJA, E ;
DIB, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591
[6]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[7]  
Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1038/nrdp.2017.85, 10.1016/S0140-6736(17)31287-4, 10.1056/NEJMc1710379]
[8]   Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial [J].
Camu, William ;
Mickunas, Marius ;
Veyrune, Jean-Luc ;
Payan, Christine ;
Garlanda, Cecilia ;
Locati, Massimo ;
Juntas-Morales, Raul ;
Pageot, Nicolas ;
Malaspina, Andrea ;
Andreasson, Ulf ;
Kirby, Janine ;
Suehs, Carey ;
Saker, Safa ;
Masseguin, Christophe ;
De Vos, John ;
Zetterberg, Henrik ;
Shaw, Pamela J. ;
Al-Chalabi, Ammar ;
Leigh, P. Nigel ;
Tree, Timothy ;
Bensimon, Gilbert .
EBIOMEDICINE, 2020, 59
[9]   The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function [J].
Cedarbaum, JM ;
Stambler, N ;
Malta, E ;
Fuller, C ;
Hilt, D ;
Thurmond, B ;
Nakanishi, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 169 (1-2) :13-21
[10]   Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival [J].
Chiot, Aude ;
Zaidi, Sakina ;
Iltis, Charlene ;
Ribon, Matthieu ;
Berriat, Felix ;
Schiaffino, Lorenzo ;
Jolly, Ariane ;
de la Grange, Pierre ;
Mallat, Michel ;
Bohl, Delphine ;
Millecamps, Stephanie ;
Seilhean, Danielle ;
Lobsiger, Christian S. ;
Boillee, Severine .
NATURE NEUROSCIENCE, 2020, 23 (11) :1339-+